Clinical trial

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients

NCT01459809

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record GLIMEPIRIDE Normalized identity: glimepirideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record METFORMIN Normalized identity: metforminView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-02-01

PhasePHASE3

Conditions

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

GLIMEPIRIDEDRUG · verified · RxNorm: glimepiride

METFORMINDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

CairoEgypt3 IstanbulTurkey (Türkiye)2 KyivUkraine2 GuadalajaraMexico2 MoscowRussia1 Saint PetersburgRussia1 SaratovRussia1 AdanaTurkey (Türkiye)1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01459809 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.